Latest Breaking News On - Futuregen biopharmaceutical co - Page 1 : comparemela.com

Through a global rights agreement with Futuregen Biopharmaceutical Co. Ltd., Abbvie Inc. continues to build its immunology portfolio to help offset losses from Humira as biosimilars tighten their grip on the mega-blockbuster.

Abbvie incFuturegen biopharmaceutical coFuturegen biopharmaceutical